Skip to content
WEKA

Accelerate Drug Discovery with Cryo-EM in the Cloud

Phil Curran
Accelerate Drug Discovery with Cryo-EM in the Cloud

Cryo-EM data processing reference design from Clovertex and WEKA simplifies and accelerates computing and data storage for Cryo-EM

Cryo-EM and HPC are helping researchers understand protein structure to accelerate the design of new medicines such as vaccines, immunotherapies, and pain management drugs. However, the computation necessary to determine 3D structure creates significant computing, data storage and cost challenges:

It can also be extremely difficult for an organization to procure and deploy the necessary infrastructure to support the needs of researchers—and keep up with rapid technology advancements. Research teams are turning to the public cloud to gain access to the computing resources they need—when they need them.

Clovertex, a specialist in bringing scientific computing applications to the cloud, and WEKA, an innovator in high performance file storage for the cloud and AI era, have joined forces to create a unique cloud-based reference design that offers significant advantages for drug companies and research scientists. This architecture can help you:

This blog describes the reference architecture in detail.

A reference design for Cryo-EM in the cloud

Our cloud design benefits from the proven cloud expertise of Clovertex combined with the power of the WEKA® Data Platform. The result is a complete and fully functional Cryo-EM data processing environment that reduces the burden on researchers, IT teams, and cloud architects while accelerating time to results.

The figure below illustrates deployment of the reference architecture on AWS.

Image

Key elements of the reference architecture include:

Reference design benefits

This architecture yields significant real-world benefits for researchers, pharmaceutical companies—and the technology teams supporting them:

These technical benefits translate to greater value from Cryo-EM, faster scientific insights, and decreased time to market for new and potentially life-saving products.

Controlling cloud costs

The ability of this reference design to automatically scale resources up or down allows you to gain much needed control over cloud costs. The reference design also helps control licensing costs by eliminating data bottlenecks and maximizing the utilization of compute resources. Most organizations need to get the maximum amount of protein structure information for the minimum spend.

This article has been co-developed with our WEKA X partner, Clovertex, a cloud organization specializing in architecting, automating, and managing applications for HPC in the cloud. Clovertex provides solutions tailored to specific research needs that allow HPC workloads to move seamlessly to the cloud.

Did this page meet your expectations?

What’s Next

Scale Production AI Faster with NeuralMesh

Your models aren't slow. Your data is. Fix AI bottlenecks with high-throughput infrastructure.